Stay updated on Fuzuloparib with AA-P in Metastatic Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the Fuzuloparib with AA-P in Metastatic Prostate Cancer Clinical Trial page.

Latest updates to the Fuzuloparib with AA-P in Metastatic Prostate Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.3%
- Check21 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference6%
- Check28 days agoNo Change Detected
- Check50 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.3%
- Check64 days agoChange DetectedThe web page has been updated to reflect a new version, changing from v2.14.4 to v2.15.0.SummaryDifference0.9%
- Check71 days agoChange DetectedThe page has updated its version from v2.14.3 to v2.14.4 and removed a date of March 25, 2025, while adding a new date of December 31, 2024.SummaryDifference1%
- Check114 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference5%
Stay in the know with updates to Fuzuloparib with AA-P in Metastatic Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fuzuloparib with AA-P in Metastatic Prostate Cancer Clinical Trial page.